Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Even before he took ...

When the FDA turns down a drug application, it has historically been up to the drug company to reveal it. These FDA complete response letters, or CRLs, have not been considered public documents.

Otter.ai CEO and founder Sam Liang has taken the company far beyond a mere AI transcription tool. The business is built on a philosophy of radical transparency which Liang says will drive the modern ...

For public school districts across Florida and much of the country, employee benefits–particularly health insurance–are among the largest and fastest-growing budget line items. But too often, decision ...

Marketers love bold words. Radical candor. Radical transparency. Radical acceptance. They sound daring, but in practice, they’re often hollow — more performance than principle. In organizations where ...